PneumoRecs VaxAdvisor vs NMV／r
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
PneumoRecs VaxAdvisor
This application offers personalized pneumococcal vaccination guidance based on patient age, vaccination history, and medical conditions. It aligns with the Advisory Committee on Immunization Practices' recommendations for U.S. immunization schedules.
- Patient-specific vaccination recommendations
- Age-based guidance
- Vaccination history tracking
- Underlying medical condition prompts
- U.S. immunization schedule compliance
Read full descriptionHide full description
This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.
NMV／r
Read full descriptionHide full description
Easily check for possible interactions of nirmatrelvir/ritonavir with different drugs. You can simultaneously search for multiple drugs to see if they can be co-administered, if they should be avoided, or if any additional adjustments are required.
Screenshots
Verdict
The clearest difference is iOS requirement: NMV／r at 15.0 against PneumoRecs VaxAdvisor's 18.0. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
PneumoRecs VaxAdvisor ships an update every 3 months, NMV／r every 2 months. The most recent releases landed on August 28, 2026 and September 19, 2026 respectively.
| Parameter | PneumoRecs VaxAdvisor | NMV／r |
|---|---|---|
| Price | Free | Free |
| Rating | 3.4 (60 ratings) — better | — |
| Positive reviews | 26.9% of reviews | — |
| Number of ratings | 60 — better | — |
| Update frequency | Every 3 months | Every 2 months — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 18.0 | 15.0 — better |
| Further details — not scored | ||
| Size | 6 MB | 2 MB |
| Age rating | 17+ | 17+ |
| Developer | Centers For Disease Control and Prevention | GARMENMED, SCP |
In-app purchases
PneumoRecs VaxAdvisor
No in-app purchases
NMV／r
No in-app purchases
Questions
Is PneumoRecs VaxAdvisor free?
Is NMV／r free?
Do PneumoRecs VaxAdvisor or NMV／r have ads?
Which is updated more often, PneumoRecs VaxAdvisor or NMV／r?
Other comparisons
